Coronavirus disease (COVID-19) Pandemic

Empfehlung des Bundesrates: Bleiben Sie zu Hause, insbesondere, wenn Sie alt oder krank sind

Information on the current situation in Switzerland

^{Information for health professionnals, FAQs, recommendations for travellers.}

Official information page

Product information

Comirnaty® - Information for healthcare professionals (in German)

Comirnaty® - Patient information (in German)

COVID-19 Vaccine Moderna - Information for healthcare professionals (in German)

COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)

COVID-19 Vaccine Moderna - Patient information (in German) (PDF, 72 kB, 22.01.2021)

ZL000_00_044e_WL Guidance document Authorisation procedures for Covid-19 medicinal products during a pandemic (PDF, 203 kB, 01.12.2020)

Questions and answers on the packaging and labelling requirements for medicinal products intended to prevent or combat COVID-19 (PDF, 125 kB, 22.12.2020)

FOPH - Coronavirus: häufig gestellte Fragen (FAQ)

(www.bag.admin.ch)

All about the vaccines - briefly and concisely explained

Vaccines: Rapid solution for new diseases?

Swismedic - The way a vaccination works

How an mRNA vaccine works

Communication regarding COVID-19

Filter by theme

Results 1 - 10 of 51

22.01.2021

Reports of suspected adverse reactions to the COVID-19 vaccines in Switzerland

Reports to date in line with the known risk profile

20.01.2021

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

12.01.2021

Swissmedic grants authorisation for the COVID-19 vaccine from Moderna

Second COVID-19 vaccine authorised in Switzerland

11.01.2021

Swissmedic warns of the danger of buying vaccines or other medicines online

If you purchase medicines or vaccines from an unregulated source you are putting your health at risk

04.01.2021

COVID-19 vaccine Comirnaty from Pfizer/BioNTech: Information for healthcare professionals concerning the sixth vaccine dose

Corona vaccine Comirnaty® (BNT162b2) from Pfizer/BioNTech: up to 6 doses per vial possible

30.12.2020

Media reports about a fatality following a COVID-19 vaccination in Switzerland: no apparent correlation with the vaccination

To date, no unknown side effects of vaccinations against the novel coronavirus have emerged

28.12.2020

Monitoring the safety of COVID-19 vaccines

To report side effects, healthcare professionals should register now for the online reporting tool ElViS

19.12.2020

Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland

Vaccine from Pfizer/BioNTech authorised in the rolling review procedure after close scrutiny of the risks and benefits

18.12.2020

Clinical trials on medicinal products - Pandemic by SARS-CoV-2

Recommendations Swissmedic / swissethics for the treatment of patients - update

11.12.2020

Benefits and risks of Covid-19 vaccines: rapid authorisations are possible, but premature vaccinations are not the answer for Switzerland

The safety of the Swiss population has top priority